Abstract
Objective: Low-carbohydrate diets should be avoided in patients receiving Sodium-Glucose Cotransporter-2 (SGLT-2) inhibitors to reduce the risk of Diabetic Ketoacidosis (DKA). High-dose acarbose has been reported to delay and reduce the absorption of carbohydrates.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Paper Title
Journal
Date
More From: Journal of Clinical Images and Medical Case Reports-------------------------
Paper Title
Journal
Date
